MIRA INFORM REPORT

 

 

Report Date :

06.02.2012

 

IDENTIFICATION DETAILS

 

Name :

AARTI INDUSTRIES LIMITED

 

 

Formerly Known As :

AARTI ORGANICS LIMITED

 

 

Registered Office :

Plot No. 801/23, G.I.D.C. Estate, Phase III, Vapi – 396 195, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

28.09.1984

 

 

Com. Reg. No.:

04-7301

 

 

CIN No.:

[Company Identification No.]

Rs.383.600 Millions

 

 

CIN No.:

[Company Identification No.]

L24110GJ1984PLC007301

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

SRTA02524E

 

 

PAN No.:

[Permanent Account No.]

AABCA2787L

 

 

Legal Form :

Public Limited Liability Company. The company’s shares are listed on the Stock Exchanges.

 

 

Line of Business :

Manufacturer, Importer and Exporter of Organic Chemicals.

 

 

No. of Employees :

1250 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (68)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 18000000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well established and reputed company having fine track. Financial position of the company appears to be sound. Directors are reported as experienced, respectable and resourceful businessmen. Trade relations are reported as fair. Business is active. Payments are reported to be regular and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.  

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

LOCATIONS

 

Registered Office/ Factory 1 :

Plot No. 801/23, G.I.D.C. Estate, Phase III, Vapi – 396 195, Gujarat, India

Tel. No.:

91-2638-25690411 / 2 / 3 / 25918195 / 55976666

Fax No.:

91-2638-25904806 / 25653186-87 / 25653185

E-Mail :

ail@bom2.vsnl.net.in

secretarial@aartigroup.com

info@aartigroup.com

Website :

www.aartigroup.com

 

 

Corporate Office :

Udyog Kshetra, II Floor, L.B.S. Marg, Mulund – Goregaon Link Road, Mulund (West), Mumbai – 400 080, Maharashtra, India

Tel. No.:

91-22-67976666 / 25918195 / 55976666

Fax No.:

91-22-25653234 / 25653185

E-Mail :

info@aartigroup.com

 

 

Factory 2:

Plot Nos. 902, GIDC Estate, Phase II, Vapi – 396 195, District Valsad, Gujarat, India

 

 

Factory 3:

Plot Nos. 752-753-754 Sarigam Industrial Area, Sarigam, Taluka Umargaon, District Valsad, Gujarat, India

 

 

Factory 4:

Plot Nos. 758/1, 758/2, Jhagadia Mega Estate, Village Kapalsadi, Taluka Jhagadia, District Bharuch, Gujarat, India

 

 

Factory 5:

Plot No. K-17/18/19, MIDC, Tarapur, District Thane, Maharashtra, India

 

 

Factory 6 :

Plot No. E-50, MIDC, Tarapur, District Thane, Maharashtra, India

 

 

Factory 7:

Plot Nos. 62, 63 and 64, Sagore, Pithampur Industrial Area, Sector-3, Pithampur, District Dhar, Madhya Pradesh, India

 

 

Factory 8:

Plot No. 286/1, 285, GIDC Estate, Phase II, Vapi – 396 195, District Valsad, Gujarat, India

 

 

Factory 9:

Plot No. 22 / C / 1 and 2, GIDC Estate, Phase I, Vapi – 396 195, District Valsad, Gujarat, India

 

 

Factory 10:

Shed No. A1-6 and 9, GIDC Estate, Phase I, Vapi – 396 195, District Valsad, Gujarat, India

 

 

Factory 11:

Plot No. 609 and 610, GIDC Estate, 100 Shed, Vapi – 396 195, District Valsad, Gujarat, India

 

 

Factory 12:

Plot Nos. 750-751, Sarigam Industrial Area, Sarigam, Taluka Umargaon, District Valsad, Gujarat, India

 

 

Factory 13:

Plot Nos. 756/4, A and B, 756/5,A and B, 756/6, A and B, 756/7, 779, Jhagadia Mega Estate, Village Kapalsadi, Taluka Jhagadia, District Bharuch – Gujarat, India

 

 

Factory 14:

Plot Nos. 756/2, A and B, 756/3,A and B, Jhagadia Mega Estate, Village Kapalsadi, Taluka Jhagadia, District Bharuch – Gujarat, India

 

 

Factory 15:

Plot No. L – 5, MIDC, Tarapur, District Thane, Maharashtra, India

 

 

Factory 16:

Plot No. L – 8, MIDC, Tarapur, District Thane, Maharashtra, India

 

 

Factory 17:

Survey No. 193/1/4, 193/1/5, 193/1/6, Silvassa, Union Territory of Silvassa.

 

 

Factory 18:

Plot No. D – 54, MIDC, Phase II, Dombivali (East), District Thane, Maharashtra, India

 

 

DIRECTORS

 

As on 31.03.2011

 

Name :

Mr. Chandrakant V. Gogri

Designation :

Chairman

 

 

Name :

Mr. Rajendra V. Gogri

Designation :

Vice Chairman and Managing Director

 

 

Name :

Mr. Shantilal T. Shah

Designation :

Vice Chairman

 

 

Name :

Mr. Ramdas M. Gandhi

Designation :

Independent Director

 

 

Name :

Mr. Laxmichand K. Jain

Designation :

Independent Director

 

 

Name :

Mr. Vijay H. Patil

Designation :

Independent Director

 

 

Name :

Mr. Haresh K. Chheda

Designation :

Independent Director

 

 

Name :

Mr. K. V. S. Shyam Sunder

Designation :

Independent Director

Date of Birth/Age :

29.07.1942 (69 years)

Qualification :

B.Com, ACA

Date of Appointment :

23.09.2008

Experience and expertise in specific functional areas :

He is a fellow member of the Institute of Chartered Accountant of India and a seasoned banker with over 30 years of enriched banking experience. He is also a Partner in Singrodia Goyal and Company. He is an expert in Corporate and Retail Banking, Risk Management, Credit Rating, Reviewing and Monitoring System and Loan Policies.

Directorships held in other

(excluding foreign)

Companies :

·         Ladderup Finance Limited

·         Liners India Limited

·         Ladderup Wealth Management Private Limited

·         Ladderup Corporate Advisory Private Limited

 

 

Name :

Mr. P A Sethi

Designation :

Independent Director

Date of Birth/Age :

19.10.1944 (66 years)

Qualification :

B.Com, CAIIB

Date of Appointment :

23.09.2008

Experience and expertise in specific functional areas :

He was an Executive Director in Vijaya Bank from March, 2003 to October, 2004. He has more than 46 years experience in Banking sector. He has worked as a General Manager and Deputy General Manager for many years.

Directorships held in other

(excluding foreign)

Companies :

·         Pro-G Agro Private Limited

·         Valuable Technologies Limited

·         Valuable Media Limited

 

 

Name :

Mr. Bhavesh R Vora

Designation :

Independent Director

Date of Birth/Age :

13.09.1967 (43 years)

Qualification :

B.Com, ACA

Date of Appointment :

23.09.2008

Experience and expertise in specific functional areas :

He is a Practicing Chartered Accountant, with more than 24 years of experience in working in the field of Stock Brokers’ Audits, Compliances, Derivatives, Futures and Options, Accounting Standards and Internal and Management Audit areas.

Directorships held in other

(excluding foreign)

Companies :

Aarti Drugs Limited

 

 

 

Name :

Mr. Sunil M Dedhia

Designation :

Independent Director

 

 

Name :

Mr. Parimal H. Desai

Designation :

Whole time Director

Date of Birth/Age :

29.05.1949 (62 years)

Qualification :

Chemical Engineer from UDCT

Date of Appointment :

28.09.1984

Experience and expertise in specific functional areas :

He has more than 33 years experience in Development and Project Implementation in the Chemical Industry.

Directorships held in other

(excluding foreign)

Companies :

·         Alchemie Dye Chem Private Limited

·         Aarti Healthcare Limited

·         Aarti Corporate Services Limited

·         Nikhil Holdings Private Limited

·         Mindcruisers Consulting Private Limited

 

 

Name :

Mr. Manoj M. Chheda

Designation :

Whole Time Director

 

 

Name :

Mr. Rashesh C. Gogri

Designation :

Whole Time Director

Date of Birth/Age :

03.06.1974 (37 years)

Qualification :

Industrial Engineer and holds Diploma in Business Management

Date of Appointment :

09.06.1997

Experience and expertise in specific functional areas :

He has more than 16 years experience in Marketing and Finance.

Directorships held in other

(excluding foreign)

Companies :

·         Aarti Healthcare Limited

·         Ganesh Polychem Limited

·         Crystal Millennium Realtors Private Limited

·         Alchemie Dye Chem Private Limited

·         Gogri and Sons Investments Private Limited

·         Alchemie Leasing and Financing Private Limited

·         Anushakti Chemicals and Drugs Limited

·         Aakansha Pharmachem Private Limited

·         Dhaval Realtors (India) Private Limited

·         Spark Academy Private Limited

 

 

Name :

Ms. Hetal Gogri Gala

Designation :

Whole Time Director

 

 

Name :

Mr. Kirit R. Mehta

Designation :

Whole Time Director

 

 

KEY EXECUTIVES

 

Name :

Ms. Mona Patel

Designation :

Company Secretary

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 31.12.2011

 

Category of Shareholders

No. of Shares

% of total No. of Shares

(A) Shareholding of Promoter and Promoter Group

 

 

(1) Indian

 

 

Individuals / Hindu Undivided Family

25,168,794

32.81

Bodies Corporate

14,135,547

18.42

Sub Total

39,304,341

51.23

(2) Foreign

 

 

Total shareholding of Promoter and Promoter Group (A)

39,304,341

51.23

(B) Public Shareholding

 

 

(1) Institutions

 

 

Mutual Funds / UTI

6,563,010

8.55

Financial Institutions / Banks

3,000

-

Foreign Institutional Investors

455,031

0.59

Sub Total

7,021,041

9.15

(2) Non-Institutions

 

 

Bodies Corporate

1,781,008

2.32

Individuals

 

 

Individual shareholders holding nominal share capital up to Rs.0.100 million

13,976,217

18.22

Individual shareholders holding nominal share capital in excess of Rs.0.100 million

14,179,581

18.48

Any Others (Specify)

457,885

0.60

Non Resident Indians

456,445

0.59

Trusts

1,440

-

Sub Total

30,394,691

39.62

Total Public shareholding (B)

37,415,732

48.77

Total (A)+(B)

76,720,073

100.00

(C) Shares held by Custodians and against which Depository Receipts have been issued

-

-

(1) Promoter and Promoter Group

-

-

(2) Public

-

-

Sub Total

-

-

Total (A)+(B)+(C)

76,720,073

-

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer, Importer and Exporter of Organic Chemicals.

 

 

Products :

Product Description

Para Nitro Chloro Benzene

ITC Code

29049005

Product Description

Ortho Nitro Chloro Benzene

ITC Code

29049004

Product Description

Sulphuric Acid

ITC Code

28070001

Product Description

Quinalphos

ITC Code

38081021

 

PRODUCTION STATUS AS ON 31.03.2011

 

Particulars

Unit

Installed Capacity

Nitro Chloro Benzenes (NCBs)

Mt. Per annum

60000

Sulphuric Acid and Allied Products (equivalent) 

Mt. Per annum

200000

 

 

Particulars

Unit

Actual Production

Nitro Chloro Benzenes (NCBs)

Mts.

30857.95

Sulphuric Acid and Allied Products (equivalent) 

Mts.

176468.96 *

Ortho Phenylene Diamine (OPDA)

Mts.

173.64

Quinalphos

Mts.

662.68

*includes 42437.87 Mts. of Sulphuric Acid 98%, exclusive of Captive Consumption.

 

GENERAL INFORMATION

 

No. of Employees :

1250 (Approximately)

 

 

Bankers :

·         Bank of Baroda

·         Union Bank of India

·         State Bank of India

·         DBS Bank Limited

·         Standard Chartered Bank

·         HDFC Bank Limited

·         Export-Import Bank of India

·         IDBI Bank Limited

·         Citi Bank N.A.

·         Axis Bank Limited

 

 

Facilities :

Secured Loan

 

Rs. In Millions

31.03.2011

Rs. In Millions

31.03.2010

LONG TERM LOANS

 

 

Non Convertible Debentures

0.000

1000.000

From Scheduled Banks

1037.600

247.370

External Commercial Borrowing

649.840

301.613

WORKING CAPITAL LOANS

 

 

From Scheduled Banks

2850.101

2461.070

Total

4537.541

4010.053

 

 

 

Unsecured Loan

 

Rs. In Millions

31.03.2011

Rs. In Millions

31.03.2010

Fixed Deposits

12.323

11.623

From Banks

461.148

315.520

From Others

251.855

27.640

Total

725.326

354.783

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Parikh Joshi and Kothare

Chartered Accountants

Address :

49/2341, M. H. B. Colony, Gandhi Nagar, Bandra (East), Mumbai – 400 051, Maharashtra, India

 

 

Associates:

·         Ganesh Polychem Limited

·         Anushakti Chemicals and Drugs Limited

·         Alchemie (Europe) Limited (w.e.f. 31st March, 2011)

·         Nascent Chemical Industries Limited (Associate of 100% Subsidiary: Aarti Corporate Services Limited)

 

 

Subsidiaries :

·         Aarti Healthcare Limited

·         Aarti Corporate Services Limited

·         Alchemie (Europe) Limited (upto 30th March, 2011)

·         Shanti Intermediates Private Limited (Through its holding Company: Aarti Corporate Services Limited)

 

 

Enterprises/Firms over which controlling individuals/key Management Personnel, of the Company along with

their relatives :

·         Alchemie Pharma Chem Limited

·         Alchemie Industries

·         Gogri and Sons Investments Private Limited

·         Alchemie Leasing and Financing Private Limited

·         Alchemie Laboratories

·         Aarti Drugs Limited

·         Spack Chemicals Private Limited

 

 

CAPITAL STRUCTURE

 

As on 31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

125000000

Equity Shares

Rs.5/- each

Rs.625.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

76720073

Equity Shares

Rs.5/- each

Rs.383.600 Millions

 

NOTES: of the above Shares –

 

·         6,22,28,216 have been issued as Fully Paid Bonus Shares.

 

·         30,00,000 have been issued to Shareholders of Salvigor Laboratories Limited pursuant to its Merger with the Company.

 

·         16,62,638 have been issued to Shareholders of Mahaval Organic Limited pursuant to its Merger with the Company.

 

·         10,25,050 have been issued to Shareholders of Alchemie Organics Limited pursuant to its Merger with the Company.

 

·         8,43,649 have been issued to Shareholders of Surfactant Specialities Limited pursuant to its Merger with the Company.

 

·         42,000 have been issued to Shareholders of Avinash Drugs Limited pursuant to its Merger with the Company.

 

·         30,25,000 have been issued towards Preferential allotment at a premium of Rs.30.65 paise per equity share to Warrant Holders.

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

383.600

383.600

364.047

2] Share Application Money       

0.000

0.000

4.428

3] Equity Share Warrants

34.800

0.000

10.784

4] Reserves & Surplus

4046.696

3603.039

3034.501

5] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

4465.096

3986.639

3413.760

LOAN FUNDS

 

 

 

1] Secured Loans

4537.541

4010.053

4344.048

2] Unsecured Loans

725.326

354.783

481.693

TOTAL BORROWING

5262.867

4364.836

4825.741

DEFERRED TAX LIABILITIES

529.393

511.073

452.073

 

 

 

 

TOTAL

10257.356

8862.548

8691.574

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

3919.807

3816.648

3667.611

Capital work-in-progress

184.461

91.450

85.476

 

 

 

 

INVESTMENT

187.621

152.512

152.780

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

2940.882
2635.375
2009.418

 

Sundry Debtors

3325.342
2564.553
2665.727

 

Cash & Bank Balances

77.660
114.101
60.241

 

Other Current Assets

2106.290
1753.620
0.000

 

Loans & Advances

474.945
468.070
1762.984

Total Current Assets

8925.119

7535.719

6498.370

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

1363.339

1469.871

722.965

 

Other Current Liabilities

23.227

14.247

25.188

 

Provisions

1573.086
1251.698
969.112

Total Current Liabilities

2959.652

2735.816

1717.265

Net Current Assets

5965.467

4799.903

4781.105

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

1.245

2.762

DEFERRED REVENUE EXPENDITURE

0.000

0.790

1.840

 

 

 

 

TOTAL

10257.356

8862.548

8691.574

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Net Sales and Other Sales Income

14618.980

12893.786

14469.783

 

 

Other Income

39.958

18.150

22.922

 

 

TOTAL                                     (A)

14658.938

12911.936

14492.705

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Manufacturing Expenses

10023.163

9215.891

10154.140

 

 

Purchase of Goods Traded in

1821.326

1139.742

922.263

 

 

Office and Administrative Expenses

186.493

149.392

136.892

 

 

Selling and Distribution Expenses

808.324

678.479

791.854

 

 

Non Operating Expenses and loss

8.086

17.649

24.390

 

 

Increase/ Decrease in Stock

(163.328)

(328.525)

42.315

 

 

TOTAL                                     (B)

12684.064

10872.628

12071.854

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

1974.874

2039.308

1020.851

 

 

 

 

 

Less

INTEREST AND FINANCIAL CHARGES  (D)

559.550

517.131

893.632

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

1415.324

1522.177

1527.219

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

479.239

447.491

387.107

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

936.085

1074.686

1140.112

 

 

 

 

 

Less

TAX                                                                  (I)

268.320

373.611

295.480

 

 

 

 

 

 

PROFIT AFTER TAX (G-I)                                  (J)

667.765

701.075

844.632

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

2587.356

2382.534

2091.079

 

 

 

 

 

Less

PRIOR YEARS ADJUSTMENT FOR OTHERS

1.030

0.857

11.384

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Transfer to General Reserve

67.000

71.000

85.000

 

 

Transfer to Debenture Redemption Reserve

0.000

200.000

200.000

 

 

Dividend

95.900

138.096

131.057

 

 

Proposed Dividend (Final)

95.900

53.704

88.434

 

 

Tax on Dividend

31.278

32.596

37.302

 

BALANCE CARRIED TO THE B/S

2964.013

2587.356

2382.534

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

5272.061

4899.126

5556.930

 

TOTAL EARNINGS

5272.061

4899.1260

5556.930

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

1175.113

1562.970

2000.988

 

 

Stores & Spares

3.923

5.265

5.114

 

 

Capital Goods

10.035

123.256

58.197

 

 

Fuel

208.260

60.776

26.938

 

TOTAL IMPORTS

1397.331

1752.267

2091.237

 

 

 

 

 

 

Earnings Per Share (Rs.)

8.70

9.14

11.46

 

QUARTERLY RESULTS

 

PARTICULARS

 

30.06.2011

30.09.2011

31.12.2011

Type

1st Quarter

2nd Quarter

3rd Quarter

Net Sales

3974.000

4070.000

4254.300

Total Expenditure

3434.400

3534.300

3597.800

PBIDT (Excl OI)

539.600

535.700

656.500

Other Income

15.600

6.100

2.500

Operating Profit

555.200

541.800

659.000

Interest

174.600

174.200

181.600

Exceptional Items

0.000

0.000

0.000

PBDT

380.600

367.600

477.400

Depreciation

128.900

132.400

136.800

Profit Before Tax

251.700

235.200

340.600

Tax

71.000

56.500

110.500

Provisions and contingencies

0.000

0.000

0.000

Profit After Tax

180.700

178.700

230.100

Extraordinary Items

0.000

0.000

0.000

Prior Period Expenses

0.000

0.000

0.000

Other Adjustments

0.000

0.000

0.000

Net Profit

180.700

178.700

230.100

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

4.56
5.43

5.83

 

 

 
 

 

Net Profit Margin

(PBT/Sales)

(%)

6.40
8.33

7.88

 

 

 
 

 

Return on Total Assets

(PBT/Total Assets}

(%)

7.29
9.47

11.21

 

 

 
 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.21
0.27

0.33

 

 

 
 

 

Debt Equity Ratio

(Total Liability/Networth)

 

1.96
1.78

1.92

 

 

 
 

 

Current Ratio

(Current Asset/Current Liability)

 

3.02
2.75

3.78

 

 

LOCAL AGENCY FURTHER INFORMATION

 

FINANCIALS

 

During the year, the Company had achieved the turnover of Rs. 15383.500 millions as against Rs. 13377.500 millions in the previous year. Operating profit before Interest, Depreciation, Tax and Non-operating expenses was at Rs. 1983.000 millions as compared to Rs. 2056.900 millions for the last year. Profit before tax had been Rs. 936.100 millions for FY 10-11 as compared to Rs. 1074.700 millions in FY 09-10.

 

Company posted Profit After Tax and Deferred Tax of Rs. 667.800 millions vis-a-vis Rs. 701.100 millions for the last year. Company’s performance was affected in mid of the year on account of the major expansion programmes carried out by the Company and hence the profitability is marginally impacted in FY 10-11 as compared to the previous year.

 

Company’s consolidated Gross Income was Rs. 15603.800 millions as compared to Rs. 13495.900 millions for the year 2009-10. Further, the share of profit from associates increased from Rs. 139.800 millions to Rs.154.400 millions in FY 2010-11. The Net Profit after consolidation of the Company was Rs. 814.900 millions vis-a-vis Rs. 823.500 millions for the last year. Consolidated EPS for FY 2010-11 was at Rs. 10.62 as against Rs. 10.73 for FY 2009-10.

 

MANUFACTURING OPERATIONS AND INNOVATIVE TECHNOLOGIES

 

The Company derives its strength from its strong Management team comprising Whole- time Directors being technocrats with sound entrepreneurial skills. They are supported by a team of loyal Scientists, Engineers, Chemists, etc. who have played an active and critical role in setting up your Company as a multi location, multi product entity with diversified end-usages/ applications. In-house R and D centers, constantly adds to the growth by continuous research on newer products, development of innovative processes to improve efficiency, yield and also to reduce the energy consumption as well as effluents. The Company has always given priority to Environment, Health and Safety and, with this principle, the Company has been constantly technologically upgrading its ETP facilities. The combined efforts of production team as well as R and D initiatives have helped the Company to become pioneer in developing various innovative processes which are more efficient and environment friendly.

 

During the year, the Company had undertaken significant expansion and up-gradation projects to improve,  enhance and diversify its range of products. During the year, the Company has also completed the process of up-gradation of its Hydrogenation Technology. The Company had earlier pioneered and commissioned an eco-friendly Buss Loop Hydrogenation Technology. Over the years the technology has been upgraded and thus the Company had taken-up this exercise to adopt this upgraded technology. The Company has been able to commission and commercialise this upgraded technology by 2nd quarter of last year. This will progressively increase the operative production capacities for its Specialty /Agro Chemicals from around 700 tpm to around 1500 tpm during FY 2011-12. With these economies of scale, the Company will be the leading global manufacturer in this range of products.

 

The Company is also in the process of setting up a 2 MW/H power plant for captive consumption. A Specialized Super-heated Boiler is being installed in this power plant which will superheat the steam. This superheated steam will be used for the dual purpose of generating power and also as process steam as required in the manufacturing processes. Hence, the variable cost for generation of power is expected to be significantly low at around Rs. 1/- per unit. This will result in an annual savings of Rs. 70.000 – 80.000 millions in power cost. This will further result into significant reduction in carbon emission in this power plant as compared to traditional power plants.

 

MARKET

 

The Company has global scale of manufacturing units with a varied mix of diversified and value added chain of products supplied to a customer base of over 600 domestic and 300 global customers. The customized delivery solutions have positioned the Company as “Preferred Supplier” to various MNCs for past several years. All this have helped the Company to emerge as a market leader in India and it also globally ranks at 1st – 5th position for more than 75% of its top 50 products. Exports for the Company had grown to Rs. 5603.900 millions in FY 2010-11 as against Rs. 5221.700 millions in FY 2009-10. Introduction of newer products will further boost the growth in Exports in coming years.

 

To facilitate the growth of the Company’s businesses in Europe, the Company has registered its key products under the REACH Regulations (which are now becoming mandatory in a phased manner for doing the business in Europe). This high cost of registration itself becomes an entry barrier especially for smaller players to enter the European markets. Thus registration would also in a way help to maintain as well as improve our presence in these related markets.

 

China: A growing market and not a threat.

 

The Company is a net exporter to China, with exports to China contributing to over 10% of total exports of the Company (Exports to China were at Rs. 584.000 millions for FY 2010-11). The Company’s backward integrated global size facilities, consistent quality, customized delivery solutions has made The Company a strategic and competitive source for various Chinese consumers. The Company, thus, looks upon China as a significant-cum-strategic growing market and not as a threat to it’s growth Plan.

 

Product Range

 

The Company is a leading manufacturer of Speciality Chemicals with diversified end-uses into Agrochemicals, Pharmaceuticals, High Performance Polymers, Paints, Pigments, Printing Inks, Rubber Chemicals, Additives, Surfactants, Dyes, Flavours and Fragrances, Home and Personal care applications, etc. The Company takes continuous efforts to explore and innovate new products and processes in all segments.

 

Agricultural Sector

 

The growth in Indian population coupled with Indian economic growth has evidenced the growth in demand for agricultural and nutritional products. The same scenario is also reflected globally as well, wherein the prices of agricultural products have been constantly increasing. The farmers are keen to maximize the produce and have increased the use of Agrochemicals to safeguard and maximize the produce. This has resulted in the global increase in demand of Agrochemicals. The Company expects the demand for Agrochemicals and Agro-based intermediates/ Agri-inputs to increase consistently. Envisaging the same, the Company has expanded its production capacity for its key Agro based Intermediates in FY 2010-11. The Company also plans to invest further in de-bottlenecking of its existing Single Super Phosphate (also known as SSP which is a commonly used fertilizer) plant to meet the growing demand.

 


High Performance Polymers

 

Increase in fuel cost has increased need for more fuel efficient modes of transportations (such as Automobiles, Aerospace, etc). While lots of innovations are being done in this regard, we expect the demand for fuel efficient technologies and its applications to grow steadily. In the process to reduce the weight, the newer carriers are now using high performance polymers as a replacement of metal components. Apart from this, these polymers also find usage in electronics, mobile communication technologies, etc. Thus the demand for these high performance polymers is expected to grow significantly. Anticipating the same, the Company had already taken R&D initiatives to develop products targeting the applications in these high performance polymers. The Company is in the process of expanding the capacities for these products as per market requirements. The Company is also in the process of developing few other products in this space and expects to launch them soon.

 

Pharmaceuticals

 

The Company had posted a growth of over 20% in its Pharmaceuticals Segment. The Company possesses two US Food and Drug Administration approved units; first one is at Tarapur for manufacture of various API products and the second one for its intermediate manufacturing unit at Vapi. While the pharmaceutical segment of the Company had reported an annual segment loss of Rs. 63.100 millions for FY 2010-2011 (Pervious year Rs. 63.600 millions), the segment had actually turned around in the last quarter of the FY 2010-11 and had break-evened at the same time with positive segment profit of Rs. 0.400 million for the last quarter of FY 2010-11. The Company expects to increase its volumes to the Regulated markets and hence expects this segment to perform better going forward and would be a key growth driver for the Company’s growth.

 

CONTINGENT LIABILITIES (As on 31.03.2011)

 

a)       Claims against the Company not acknowledged as Debts Rs.121.518 millions. 

 

b)       In respect of Letters of Credit, Bank Guarantees issued and Bills discounted by the Company’s Bankers Rs.402.446 millions

 

c)       Estimated amount of Contracts remaining to be executed on capital account and not provided for, net of advances, Rs.127.896 millions.

 

Fixed Assets

 

·         Leasehold Land

·         Freehold Land

·         Building

·         Plant and Machinery

·         Furniture and Fixture and Office Equipment

·         Vehicles

 

AUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED 31ST DECEMBER 2011

 

       (Rs. In Millions)

PARTICULARS

3 Months

9 Months

 

Ended 31.12.2011

Audited

Ended 30.09.2011

Audited

Ended 31.12.2011

Audited

1. Gross Sales

4345.300

4170.200

12604.300

Less: Excise Duty

196.400

195.300

592.100

a) Net Sales

4148.900

3974.900

12012.200

b) Add : Other Operating Income

105.400

95.100

286.200

Total

4254.300

4070.000

12298.400

 

 

 

 

2. Expenditure

 

 

 

(a) (Increase)/decrease in Stock in Trade and work in progress

(96.000)

(165.000)

(278.800)

(b) Consumption of Raw Materials

2107.600

2194.300

6342.800

(c) Purchase of Traded Goods

304.300

350.300

1023.700

(d) Employee cost

131.600

106.700

332.700

(e) Depreciation

136.800

132.400

398.100

(f) Other Expenditure

1150.300

1048.000

3146.200

Total

3734.600

3666.700

10964.700

3. Profit From Operations before other Income, Interest & Exceptional Items (1-2)

519.700

403.300

1333.700

4. Other Income

2.500

6.100

24.200

5. Profit before Interest and Exceptional items (3+4)

522.200

409.400

1357.900

6. Interest

181.600

174.200

530.400

7. Profit after interest before Exceptional items (5-6)

340.600

235.200

827.500

8. Exceptional items

--

--

--

9. Profit from Ordinary Activities before tax (7-8)

340.600

235.200

827.500

10. Tax Expenses

 

 

 

a) Provision for Taxation – Current

110.000

55.000

225.000

b) Provision for Deferred tax

0.500

1.500

13.000

Total

110.500

56.500

238.000

11. Net Profit from Ordinary Activities after tax (9-10)

230.100

178.700

589.500

12. Extraordinary items

--

--

--

13. Net Profit (11-12)

230.100

178.700

589.500

14. Paid Up Equity Share Capital (Face Value Rs.5/- each )

383.600

383.600

383.600

15. Reserves and Surplus excluding revaluation reserve

--

--

--

16. Basis and Diluted EPS (Rs.)

3.00

2.33

7.68

17. Aggregate of Public Shareholding

 

 

 

- Number of Shares

37415732

38306112

37415732

- Percentage of Shareholding (%)

48.77

49.93

48.77

18. Promoters and Promoter group share holding

 

 

 

a) Pledged / Encumbered

 

 

 

- Number of Shares

Nil

Nil

Nil

- Percentage of share (as a % of the total shareholding of promoter and promoter group)

Nil

Nil

Nil

- Percentage of shares(as a % of the total share capital of the company)

Nil

Nil

Nil

b) Non-encumbered

 

 

 

- Number of Shares

39304341

38413961

39304341

- Percentage of Share (as a % of the total shareholding of promoter and promoter group)

100.00

100.00

100.00

 - Percentage of Share (as a % of the total share capital of the company)

51.23

50.07

51.23

           


Notes

 

1.       The above results for the quarter and nine months ended 31st December, 2011 have been reveiwed by the Audit Committee and approved by the Board of Directors in their Meeting held on 1st February 2012.

 

2.       The Board of Directors have declared Interim Dividend of Rs.2.00 ps. Per Equity Share of Rs.5/- each amounting to Rs.153.440 millions and 7th February, 2012 has been fixed as record date for the payment of the said Interim Dividend.

 

3.       Details of Investors Complaints received for the quarter ended 31st December, 2011. Beginning:- NIL Received :- 8 Resolved:- 8 Pending:- NIL

 

SEGMENTWISE REVENUE AND RESULTS UNDER CLAUSE 41 OF LISTING AGREEMENT

 

(Rs. In Millions)

PARTICULARS

3 Months

9 Months

 

Ended 31.12.2011

Audited

Ended 30.09.2011

Audited

Ended 31.12.2011

Audited

 

 

 

 

1. Segment Revenue

 

 

 

a) Performance Chemicals

2589.000

2605.000

8021.300

b) Agri - Intermediates and Fertilizers

1007.200

844.200

2456.100

c) Pharmaceuticals

443.500

414.300

1244.900

d) Home and Personal Care Chemicals

411.000

401.800

1168.200

Total

4450.700

4265.300

12890.500

 

 

 

 

2. Segment Results Profit / (Loss)

 

 

 

Before Tax and Interest From each Segment

 

 

 

a) Performance Chemicals

354.900

308.200

995.400

b) Agri - Intermediates and Fertilizers

208.500

169.600

531.900

c) Pharmaceuticals

22.700

3.200

34.300

d) Home and Personal Care Chemicals

16.400

7.300

35.600

Total 

602.500

488.300

1597.200

 

 

 

 

Less : Interest

181.600

174.200

530.300

Other Unallocable Expenditure (Net)

80.300

78.900

239.500

 

 

 

 

Total Profit Before Tax

340.600

235.200

827.400

 

Segmental Capital Employed :

 

Fixed assets used in the Company’s business or liabilities contracted have not been identified to any of the reportable segments, as the Fixed Assets and services are used interchangeably between segments. The Company believes that it is currently not practicable to provide segment disclosures relating to capital employed.

 

Re-Classification of Business Segments :

 

For better understanding of businesses, the Company has re-classified its business segments based on the nature of product and their respective end-uses. Based on the same, the Company has reclassified its business segments into Performance Chemicals, Agri-Intermediates and Fertilizers, Pharmaceuticals and Home and Personal Care. This change does not have any financial impact.

 

WEB SITE DETAILS

 

PROFILE

 

Subject is an India-based company engaged in manufacturing of dyes, pigments, pharmaceuticals, agrochemicals and rubber chemicals. Subject primarily produces Benzene-based basic and intermediate chemicals in India. The Company operates in four segments: Basic Chemicals, Specialty Chemicals, Agro Chemicals and Pharmaceuticals. Subject has 16 manufacturing units spread across Gujarat and Maharashtra and also has a research and development facility. The Company’s products include para nitro chloro benzene (PNCB), ortho nitro chloro benzene (ONCB), para dichloro benzene (PDCB), ortho dichloro benzene (ODCB), nitro benzene, alkylated anilines and toluidines, chloro phenols, fluoro compounds and bulk drug intermediates. The Company operates in United States of America, Europe, Japan and India. For the fiscal year ended 31 March 2010, Subject’s revenues increased 11% to RS13.03B. Net income decreased 13% to RS823.5M. Revenues reflect increased sales from Pharmaceuticals business segments. Net income was offset by lower other income, an increase in purchase of goods traded in, higher depreciation expense. The Company is into the manufacturing of dyes, pigments, pharmaceuticals etc.

 

MANAGEMENT

 

CHANDRAKANT V. GOGRI - NON-EXECUTIVE CHAIRMAN OF THE BOARD

 

Shri. Chandrakant V. Gogri is Non-Executive Chairman of the Board of Aarti Industries Limited. After graduation, while working as plant engineer and later as project engineer, he as experience in chemical manufacturing before venturing on his own. An experience encompassing Projects, Operations, Process Development and Local and International Marketing, in the Chemical Industry. Further, his business acumen and flair for finance has stood the test of time during the growth of the AARTI GROUP. He is one of the main Promoter of the Company. He is Chairman and Member of the Board of Directors of various Aarti Group Companies. His business acumen, entrepreneurial zeal and organizational skill has been much helpful to the Company to grow. His qualification is B.E. (Chem), (UDCT, Mumbai), DBM. He has been Director of the following companies Aarti Drugs Limited, Aarti Healthcare Limited, Aarti Corporate Services Limited, Crystal Millennium Realtors Private Limited.

 

Education

B, University of Mumbai

 

RAJENDRA V. GOGRI - EXECUTIVE VICE CHAIRMAN OF THE BOARD, MANAGING DIRECTOR

 

Shri. Rajendra V. Gogri is Executive Vice Chairman of the Board, Managing Director of Aarti Industreis Limited. He is a Chemical Engineer from UDCT and has Masters Degree in Chemical Engineering from U.S.A. He has experience of over 24 years in Chemical Industry handling production, marketing, export and finance activities.

 

Education

BE Chemical Engineering, Mumbai University Institute of Chemical Technology

 

SHANTILAL TEJSHI SHAH - NON-EXECUTIVE VICE CHAIRMAN OF THE BOARD

 

Shri. Shantilal Tejshi Shah is Non-Executive Vice Chairman of the Board of Aarti Industries Limited. He is a commerce graduate and is one of the main promoters of the Aarti Group. He has about 45 years of experience in marketing, finance and administrative functions in the chemical industry. Earlier, he has been Joint Managing Director of the Company and presently, he is Non-executive Vice Chairman of the Company. He is a Director in Aarti Drugs Limited, Nascent Chemical Industries Limited, Surfactant Specialities Limited, Aarti Corporate Services Limited. Committee Membership held by him are as under: He is a member in Audit Committee, Remuneration Committee, Share Holders Grievance Committee of Aarti Drugs Limited and a member in Shareholders grievance committee of Aarti Industries Limited.

 

HARESH K. CHHEDA - NON-EXECUTIVE INDEPENDENT DIRECTOR

 

Shri. Haresh K. Chheda is Non-Executive Independent Director of Aarti Industries Limited. He is a Chartered Accountant by profession and has over 16 years experience in the field. He is a senior partner of Ghalla Bhansali, Chartered Accountants, Mumbai.

 

MANOJ M. CHHEDA - WHOLE-TIME DIRECTOR

 

Shri. Manoj M. Chheda is Whole-time Director of Aarti Industries Limited, since November 1993. He has wide experience of over 22 years in purchase and marketing of Chemicals. His qualification is B.Com.

 

SUNIL M. DEDHIA - NON-EXECUTIVE INDEPENDENT DIRECTOR

 

Shri. Sunil M. Dedhia is Non-Executive Independent Director of Aarti Industries Limited. He is a Practicing Company Secretary and has over 19 years of experience in the field of Corporate Laws. He has been Director of the following companies Aarti Drugs Limited, Anushakti Chemicals and Drugs Limited, Professional Realtors Private Limited.

 

PARIMAL H. DESAI - WHOLE-TIME DIRECTOR

 

Shri. Parimal H. Desai is Whole-time Director of Aarti Industries Limited. He is a Chemical Engineer from UDCT with more than 30 years experience in development and project implementation in the Chemical industry.

 

HETAL GOGRI GALA - WHOLE-TIME DIRECTOR

 

Smt. Hetal Gogri Gala is Whole-time Director of Aarti Industries Limited. Her qualification is B. E (Electronics) and MEP degree from IIMS Ahmedabad. She is having experience in the Business Administration, Financial Management and Purchase. Directorships held in other (excluding foreign) Companies are Anushakti Chemicals and Drugs Limited Ganesh Polychem Limited Gogri And Sons Investments Private Limited, Aichemie Dye Chem Private Limited.

 

Education

·         BE Electronics, Indian Institute of Management, Ahmedabad

·         Indian Institute of Management, Ahmedabad

 

RAMDAS M. GANDHI - NON-EXECUTIVE INDEPENDENT DIRECTOR

 

Shri. Ramdas M. Gandhi is Non-Executive Independent Director of Aarti Industries Limited. He is a LLM, Solicitor and has been in practice for over 50 years and has experience in the legal field and particularly on the matters relating to corporate laws. Directorships held in other (excluding foreign) Companies are Vinyl Chemicals (India) Limited, Unichem Laboratories Limited, Aarti Drugs Limited Pidilite Industries Limited.

 

Education

M Law, University of Mumbai

 


RASHESH C. GOGRI - WHOLE-TIME DIRECTOR

 

Shri. Rashesh C. Gogri is Whole-time Director of Aarti Industries Limited. He is an Industrial Engineer and holds Diploma in Business Management and has more than 12 years experience in Marketing and Finance. He is Director of some of the companies of Aarti Group of Industries including flagship Company Aarti Industries Limited.

 

LAXMICHAND K. JAIN - NON-EXECUTIVE INDEPENDENT DIRECTOR

 

Shri. Laxmichand K. Jain is Non-Executive Independent Director of Aarti Industries Limited. He is an Environmental with over 42 years of experience in the industry. His qualification is B.E. (Chem), USA.

 

KIRIT R. MEHTA - WHOLE-TIME DIRECTOR

 

Shri. Kirit R. Mehta is Whole-time Director of Aarti Industries Limited. He has has wide experience in dealing with Government authorities at Vapi, Sarigam and Jhagadia at Gujarat and Tarapur in Maharashtra where Company's manufacturing units are located. He was the President of Federation of Industries Association Gujarat, Executive Member of Gujarat Chamber of Commerce and Industries, the President of Sarigam Industries Association and the President of Vapi Industries Association. His qualification is B.Com. He has been Director of the following companies Ganesh Polychem Limited, Anushakti Chemicals and Drugs Limited, Shanti Intermediates Private Limited, Amrey Enterprises Private Limited.

 

PREMCHANDRA A. SETHI - NON-EXECUTIVE INDEPENDENT DIRECTOR

 

Shri. Premchandra A. Sethi is Non-Executive Independent Director of Aarti Industries Limited. He was an Executive Director in Vijaya Bank from March, 2003 to October, 2004. He has more than 46 years experience in banking sector. He has worked as a General Manager and Deputy General Manager for many years. He has been Director of Jyoti Structures Limited, IDBI Capital Market Services Limited, Indiabulls Asset Management Company Limited. His qualification is B.Com, CAIIB

 

K. V.S. SHYAM SUNDER - NON-EXECUTIVE INDEPENDENT DIRECTOR

 

Shri. K. V. S. Shyam Sunder is Non-Executive Independent Director of Aarti Industries Limited. He is a fellow member of the Institute of Chartered Accountant of India and a seasoned banker with over 30 years of enriched banking experience. He is also a Partner in Singrodia Goyal and Company. He is an in Corporate and Retail banking, Risk Management, Credit Rating, Reviewing and Monitoring System and loan policies. He has been Director of the following companies Ladderup Finance Limited, Liners India Limited, Ladderup Corporate Advisory Private Limited.

 

BHAVESH R. VORA - NON-EXECUTIVE INDEPENDENT DIRECTOR

 

Shri. Bhavesh R. Vora is Non-Executive Independent Director of Aarti Industries Limited. He is a Practicing Chartered Accountant, with more than 22 years of experience in working in the field of Stock Brokers' Audits, Compliances, Derivatives, Futures and Options, Accounting Standards and Internal & Management Audit areas. He has been Director of Aarti Drugs Limited.

 

 


NEWS

 

PRESS RELEASE

 

AARTI INDUSTRIES LIMITED: Q2 RESULTS UPDATE.

 

Operating Income: Rs.4070.000 millions (Increase by 25%)     

EBIDTA: Rs.536.000 millions (Increase by 31%)

PAT: Rs.179.000 millions (Jump of 59%)

 

Aarti Industries Limited is a manufacturer of Speciality Chemicals with diversified end-uses into Performance Chemicals, Agri-Intermediates and Fertilizers, Pharmaceuticals and Home and Personal Care chemicals, etc.

 

The Company’s Net Sales and Related Income for Q2 2011-12 jumped by around 25% to Rs.4070.000 millions (previous year Rs.3259.000 millions). Similarly, EBIDTA for the quarter increased by 31% from Rs.410.000 millions in respect of Q2 2010-11 to Rs.536.000 millions for Q2 2011-12. The interest cost for the company had also increased from Rs.133.000 millions for Q2 2010-11 to Rs.174.000 millions for Q2 2011-12, mainly on account of prevailing higher interest rates. Inspite of higher interest cost, PAT registered the growth of about 59% from Rs.113.000 millions to Rs.179.000 millions for the same period. The Company’s EPS for Q2 2011-12 stood at Rs.2.33 as against Rs.1.47 for the Q2 2010-11.

 

Likewise the Company’s half yearly PAT also registered the growth of about 15% from Rs.313.000 millions for first half 2010-11 to Rs.359.000 millions for first half 2011-12. The Company’s half yearly EPS was at Rs.4.68 (previous year Rs.4.08).

 

The company had achieved exports revenue of Rs.3293.400 crs during the first half of FY 2011-12, as compared to Rs.2458.000 millions for the similar period last year, thereby posting an increase of about 34%. The growth in Exports is mainly due to the increase in volumes of exports as well as introduction of newer products. With steep depreciation in Indian Rupee, the company on an overall basis expects to benefits from its increasing exports. 

 

BOARD MEETING ON FEB 09, 2012

 

India, February 02 -- Aarti Industries Limited has informed BSE that Shri Chandrakant V. Gogri, Founder Chairman of the Company has indicated to retire as the Chairman and Director of the Company upon attaining age of 66 years on August 16, 2012.In view of the above, a meeting of the Board of Directors of the Company will be held on February 09, 2012, to consider and approve succession plan.

 

FINANCIAL RESULT UPDATES

 

India, February 01 -- Aarti Industries Limited has submitted to the Exchange the Standalone Financial Results for the period ended December 31, 2011.

 

FINANCIAL RESULTS AND AUDIT REPORT FOR DEC 31, 2011

 

India, February 01 -- Aarti Industries Limited about the Financial Results and a copy of the Audit Report for the period ended December 31, 2011.

 

BOARD DECLARES INTERIM DIVIDEND

 

India, February 01 -- Aarti Industries Limited has informed BSE that the Board of Directors of the Company at its meeting held on February 01, 2012, has declared Interim Dividend @ Rs.2.00 ps. (40%) per share for the financial year 2011-2012.The aforesaid Interim Dividend will be dispatch to registered members of the Company on February 10, 2012.


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.48.96

UK Pound

1

Rs.77.47

Euro

1

Rs.64.40

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

7

PAID-UP CAPITAL

1~10

7

OPERATING SCALE

1~10

8

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

8

--PROFITABILIRY

1~10

7

--LIQUIDITY

1~10

8

--LEVERAGE

1~10

8

--RESERVES

1~10

8

--CREDIT LINES

1~10

7

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

68

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.